International Psoriasis Council
Publications & Slides
IPC Psoriasis Review
Join our mailing list so you will be notified when a new issue is available. Download PDF files below.
-
IPC Psoriasis Review - December 2011 - Spanish version : December 2011 IPC Psoriasis Review Spanish version.
-
IPC Psoriasis Review - December 2011 - Portuguese version : 2011 December Psoriasis Review - Portuguese version
-
IPC Psoriasis Review - December 2011 : This issue of the IPC Psoriasis Review presents Clinical and Scientific Advances from the 20th Congress of the Academy of Dermatology and Venereology, Lisbon Portugal and is available for CME credits.
Format: Monograph Credit Designation: 1.0 credit(s) Expiration Date: December 31, 2013
Program Overview The goal of this program is to provide important clinical and scientific data on the treatment of psoriasis.
Target Audience
This activity has been designed to meet the educational needs of dermatologists and health care providers involved in the care of patients with psoriasis.
Learning Objectives
Upon completion of this activity, participants will be able to:
1)Review and analyze the benefit to risk differences between approved psoriasis therapeutic agents and incorporate these into clinical practice
2) Discuss the relative mechanisms of action of approved therapies and those in clinical development
3) Apply new knowledge and learning to practice techniques to more effectively and optimally manage the psoriasis patient
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Purdue University College of Pharmacy, the International Psoriasis Council and Focus Medical Communications. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Purdue University School of Pharmacy designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit (s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
All faculty and staff involved in the planning or presentation of continuing education activities sponsored/ provided by Purdue University College of Pharmacy are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of their presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Focus Medical Communications staff, International Psoriasis Council staff and Purdue University College of Pharmacy staff have no relationships to disclose.
Dr. Firas Al-Niaimi
Dr. Firas Al-Niaimi has not served as an investigator, speaker or consultant for any pharmaceutical companies.
Professor Esteban Dauden, MD, PhD
Professor Esteban Dauden has received grants and research support from Abbott, Janssen, Pfizer and MSD. He has served as a consultant/speaker bureau for Abbott, Janssen-Cilag, Pfizer, MSD, Leo Pharma and Novartis. He has also served on advisory boards for Abbott, Janssen-Cilag, Pfizer, MSD, Amgen, Centocor, Leo Pharma and Celgene.
Professor Yves Poulin, MD, FRCPC, FAAD
Professor Poulin has received grants/research support from Abbott, Amgen, Centocor, Janssen, Leo Pharma, Merck and Pfizer. He has served on an advisory boards from Abbott, Amgen and Janssen and has received honorarium from Abbott, Amgen, Janssen and Leo Pharma. He also received an unrestricted educational grant from Abbott.
Accredited by:
Purdue University Program Sponsored By:
This material was supported by an educational grant from Abbott, Amgen and Janssen Biotech, Inc. -
IPC Psoriasis Review – July 2011 : This issue of the IPC Psoriasis Review presents a review of the Clinical & Scientific Advances from the American Academy of Dermatology’s 69th Annual Meeting held in New Orleans, Louisanna and is available for CME credits.
Format: Monograph Credit Designation: 1.0 credit(s) Expiration Date: September 21, 2012
Program Overview The goal of this program is to provide important clinical and scientific data on the treatment of psoriasis.
Target Audience
This activity has been designed to meet the educational needs of dermatologists and health care providers involved in the care of patients with psoriasis.
Learning Objectives
Upon completion of this activity, participants will be able to: 1) Review and analyze the benefit to risk differences between approved psoriasis therapeutic agents and incorporate these into clinical practice 2) Discuss the relative mechanisms of action of approved therapies and those in clinical development 3) Apply knew knowledge and learning to practice techniques to more effectively and optimally manage the patient
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Purdue University College of Pharmacy, the International Psoriasis Council and Focus Medical Communications. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Purdue University School of Pharmacy designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit (s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
All faculty and staff involved in the planning or presentation of continuing education activities sponsored/ provided by Purdue University College of Pharmacy are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of their presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Focus Medical Communications staff, International Psoriasis Council staff and Purdue University College of Pharmacy staff have no relationships to disclose.
Dr. Firas Al-Niaimi
Dr. Firas Al-Niaimi has not served as an investigator, speaker or consultant for any pharmaceutical companies.
Dr. Kenneth Gordon
Dr. Kenneth Gordon has grant/research support from Abbott, Amgen, Centocor, Pfizer and Celgene. He has served as a consultant to Abbott, Amgen, Centocor, Pfizer, Novartis and Merck.
Dr. Murlidhar Rajagopalan
Dr. Murlidhar Rajagopalan has been a consultant for MSD, Schering Plough and an advisory board member and honorarium recipient from Pfizer (Wyeth).
Accredited by:
Purdue University Program Sponsored By:
This material was supported by an educational grant from Abbott, Amgen and Janssen Biotech, Inc. -
IPC Psoriasis Review - July 2011 - Spanish : Spanish version of the July 2011 IPC Psoriasis Review.
-
IPC Psoriasis Review - July 2011 - Portuguese : Portuguese version of the July 2011 IPC Psoriasis Review.
-
IPC Psoriasis Review - December 2010 : This issue of the IPC Psoriasis Review presents a review of the The 19th congress of the European Academy of Dermatology and Venereology held in Gothenburg, Sweden. This review also provides you an opportunity to gain 1.0 AMA credit. In addition, we have provided an overview of the difficult cased presented during our Meet the Experts program from Gothenberg. IPC gratefully acknowledges our co-editors Richard Warren, M.D., Ph.D for his contributions to the December 2010 IPC Psoriasis Review.
*This issue is also available in Spanish and Portuguese. -
IP Psoriasis Review - December 2010 - Portuguese : Portuguese version.
-
IP Psoriasis Review - December 2010 - Spanish : Spanish version.
-
IP Psoriasis Review - September 2010 - Portuguese : Portuguese translation.
-
IPC Psoriasis Review - September 2010 - English : This issue of the IPC Psoriasis Review presents the Top Ten Clinical and Research papers for 2009/2010, selected by the IPC Membership, that we believe make the greatest impact to our understanding of the disease and its treatment. In addition, we highlight treating psoriasis in different areas of Europe. IPC gratefully acknowledges our co-editors Dr. Catherine Smith of St John's Institute of Dermatology, London and Dr. Arthur David Burden of the University of Glasgow, Scotland for their contributions to the September 2010 IPC Psoriasis Review.
*This issue is also available in Spanish and Portuguese. -
IP Psoriasis Review - September 2010 - Spanish : Spanish version.
-
IPC Psoriasis Review - May 2010 - Spanish : Spanish version of the May 2010 IPC Psoriasis Review
-
IPC Psoriasis Review - May 2010 - Portuguese : Portuguese version of the May 2010 IPC Psoriasis Review.
-
IPC Psoriasis Review - May 2010 - English : This issue of the IPC Psoriasis Review focuses on treating psoriasis in Asia-Pacific. In addition, it highlights scientific updates from the 70th Annual Meeting of the Society for Investigative Dermatology. IPC gratefully acknowledges our co-editor Professor Lars Iversen, Department of Dermatology, Aarhus University Hospital, Denmark, for his contribution to the May 2010 IPC Psoriasis Review.
This issue is also available in Spanish and Portuguese. -
IPC Psoriasis Review - December 2009 - Spanish : December 2009 Spanish version
-
IPC Psoriasis Review - December 2009 - Portuguese : December 2009 Portuguese version
-
IPC Psoriasis Review - December 2009 - English : In this issue and upcoming issues of the IPC Psoriasis Review, we deliver a focus on select regions throughout the world. In this issue we will focus on Latin American. We have also presented select clinical cases from our October 2009 IPC Meet the Experts Program which was chaired by Professor Wolfram Sterry and conducted at the 18th European Academy of Dermatology and Venereology (EADV) Congress in Berlin Germany.
This issue is also available in Spanish and Portuguese. -
IPC Psoriasis Review – September 2009 - Portuguese : September issue Portuguese version
-
IPC Psoriasis Review - September 2009 - Spanish : Spanish version of September issue
-
IPC Psoriasis Review - May 2009 : IPC Psoriasis Review - Vol. 5, No. 1 – May 2009
-
IPC Psoriasis Review - September 2009 : Under the leadership of Professors Ricardo Romiti and Errol Prens, IPC presents its 2009 review of the top research and clinical manuscripts in the field of psoriasis. We have also presented select clinical cases from our June 2009 IPC Meet the Experts Program, conducted at the 2nd World Psoriasis & Psoriatic Arthritis Conference in Stockholm and chaired by Professor Jonathan Barker.
-
IPC Psoriasis Review - December 2008 : Under the leadership of Prof. Giampiero Girolomoni and Dr. Kenneth Gordon, IPC published the sixth issue of the IPC Psoriasis Review in December 2008. The issue included highlights of psoriasis data presented at the 17th European Academy of Dermatology and Venereology (EADV) Congress 2008 and the 5th International Congress Psoriasis from Gene to Clinic 2008. We also presented a case from our September 2008 IPC Meet the Experts symposium, conducted at the EADV meeting and chaired by Prof. Wolfram Sterry. Additional cases can be reviewed at cme.medscape.com/viewprogram/17780. Vol. 4, No. 3
-
IPC Psoriasis Review - September 2008 : Under the leadership of Professor Hervé Bachelez and Professor Mona Ståhle, IPC published the fifth issue of the IPC Psoriasis Review in September 2008. This issue presented IPC's view of the ten most important clinical and research publications of the year. We also presented select cases from our May 2008 IPC Meet the Experts Program, conducted at the Spring EADV meeting and chaired by Professor Christopher Griffiths. Vol. 4, No. 2
-
IPC Psoriasis Review - May 2008 : Under the leadership of Dr. Craig Leonardi and Dr. Fernando Stengel, IPC published the fourth issue of the IPC Psoriasis Review in May 2008. The issue included highlights of psoriasis data presented at the 21st World Congress of Dermatology 2007 and the 66th Annual Meeting of the American Academy of Dermatology (AAD) 2008. We also presented select cases from our February 2008 IPC Meet the Experts Program, conducted at the AAD meeting and chaired by Dr. Kenneth Gordon.
Vol. 4, No. 1 -
IPC Psoriasis Review - Vol. 3, No. 1 : Under the leadership of Dr. Alexa Kimball and Dr. Ulrich Mrowietz, IPC published the third issue of the IPC Psoriasis Review in the Fall of 2007. The issue presented IPC's view of the eleven most important clinical and research publications of the year. The newsletter was designated for CME credit by the A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System, Dallas and was disseminated to over 10,000 dermatologists internationally.
-
IPC Psoriasis Review - Vol. 2, No. I : Under the leadership of Professor Wolf-Henning Boehncke, Dr. Bruce Strober, and Dr. Alan Menter, IPC just released the second issue of the IPC Psoriasis Review. The issue presents IPC's view of the ten most important clinical and research publications of the past year. The newsletter was designed for CME credit by the A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System, Dallas and will be disseminated to over 10,000 dermatologists internationally.
-
IPC Psoriasis Review - Vol. 1, No. 1 : Under the leadership of Professor Jean-Paul Ortonne, Dr. John Sullivan, and Dr. Alan Menter, IPC published the first issue of the IPC Psoriasis Review in the Fall of 2005. The issue presented IPC's view of the ten most important clinical and research publications of the year. The newsletter was designed for CME credit by the A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System, Dallas and was disseminated to over 10,000 dermatologists internationally.